CMCM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CMCM is not a good buy right now for a beginner, long-term investor with $50,000-$100,000 to deploy. The stock lacks a strong technical uptrend, has no recent news catalyst, no supportive insider or hedge fund activity, and its latest quarter showed revenue growth but weak profitability. The setup is more neutral than bullish, so the best call is to hold and wait for clearer confirmation.
CMCM is trading at 5.33 with the market closed, flat versus the previous close, and slightly under short-term pressure. MACD histogram is positive and expanding, which is a mild bullish sign, but RSI_6 at 40.78 is still neutral and not showing strong momentum. The moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend is still weak. Key levels: pivot 5.499, resistance 5.79/5.969, support 5.209/5.03. Overall, the technical picture is mixed to bearish, not an ideal long-term entry.
["2025/Q4 revenue increased 30.27% YoY, showing top-line growth.", "MACD histogram is positive and expanding, suggesting improving near-term momentum.", "Open interest put-call ratio at 0.86 is mildly constructive."]
["No news in the recent week, so there is no event-driven catalyst.", "Net income fell to -202.071 million, showing poor profitability.", "EPS declined to -0.13 and gross margin dropped to 66.5%, both negative trends.", "Bearish moving average structure remains in place.", "No meaningful hedge fund, insider, or congress buying activity was reported.", "AI Stock Picker and SwingMax both show no signal today."]
In 2025/Q4, CMCM delivered strong revenue growth, with revenue up 30.27% YoY to 308.851 million. However, the quarter was still financially weak overall because net income fell to -202.071 million, EPS dropped to -0.13, and gross margin declined to 66.5%. This means the company is growing sales but not converting that growth into better earnings quality. Latest quarter season: 2025/Q4.
No analyst rating or price target change data was provided, so there is no visible recent Wall Street upgrade/downgrade trend to support a buy case. Based on the available information, the Wall Street pros view is limited because there is no fresh analyst momentum, while the cons view dominates due to weak earnings, falling margins, and lack of catalysts.
